access to new medicine

3:03PM
Printer-friendly version
Trudeau government advisors prescribe vast bureaucracy to manage national pharmacare

Unfortunately, the federal government’s track record of creating reliable and accurate data systems is not good.


2:00AM
Printer-friendly version

Innovative new medicines can have a profound impact on the health and wellbeing of those stricken with illness. Unfortunately, Canadians are often denied these benefits for months, if not years, while they wait for their government to approve drugs already deemed safe and effective by regulators in the European Union and United States. Smarter regulation could save resources, reduce patient suffering, and improve the lives of Canadians.